Generate Biomedicines, Inc.
GENB$1.68B
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaSOMERVILLE
Drugs in Pipeline
1
Phase 3 Programs
1
Upcoming Catalysts
2
Next Catalyst
Jun 8, 2026
8dMarket Overview
Stock performance and key metrics
GENB News
Catalyst Timeline
2 upcoming, 1 past
ConferenceNext
Conference
Jun 8, 2026AI-detected
Generate Biomedicines announced its participation in the Goldman Sachs 47th Annual Global Healthcare Conference scheduled for June 8, 2026, with a live webcast expected to be available.
Source1 more catalyst beyond 14 days
Start a 48h free trial to see all upcoming catalysts
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
GB-0895 | Phase 3 | Severe Asthma | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply